Skip to main content
Top
Published in: Diabetologia 12/2013

01-12-2013 | Article

Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus

Authors: Anny H. Xiang, Miwa Takayanagi, Mary Helen Black, Enrique Trigo, Jean M. Lawrence, Richard M. Watanabe, Thomas A. Buchanan

Published in: Diabetologia | Issue 12/2013

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to compare longitudinal changes in insulin sensitivity (SI) and beta cell function between women with and without a history of gestational diabetes mellitus (GDM).

Methods

The prospective follow-up cohort included 235 parous non-diabetic Mexican–American women, 93 with and 142 without a history of GDM. The participants underwent dual-energy x-ray absorptiometry, OGTTs and IVGTTs at baseline and at a median of 4.1 years follow-up. The baseline values and rates of change of metabolic measures were compared between groups.

Results

At baseline, women with prior GDM (mean age 36.3 years) had similar values of SI but higher percentages of body fat and trunk fat (p ≤ 0.02), a lower acute insulin response and poorer beta cell compensation (disposition index [DI]) (p < 0.0001) than women without GDM (mean age 37.9 years). During the follow-up, women with GDM had a faster decline in SI (p = 0.02) and DI (p = 0.02) than their counterparts without GDM, with no significant differences in changes of weight or fat (p > 0.50). Adjustment for baseline age, adiposity, calorie intake, physical activity, age at first pregnancy, additional pregnancies and changes in adiposity during follow-up increased the between-group differences in the rates of change of SI and DI (p ≤ 0.003).

Conclusions/interpretation

Mexican–American women with recent GDM had a faster deterioration in insulin sensitivity and beta cell compensation than their parous counterparts without GDM. The differences were not explained by differences in adiposity, suggesting more deleterious effects of existing fat and/or reduced beta cell robustness in women with GDM.
Literature
1.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779PubMedCrossRef Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779PubMedCrossRef
2.
go back to reference Xiang AH, Li BH, Black MH et al (2011) Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus. Diabetologia 54:3016–3021PubMedCrossRef Xiang AH, Li BH, Black MH et al (2011) Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus. Diabetologia 54:3016–3021PubMedCrossRef
3.
go back to reference Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMedCrossRef Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMedCrossRef
4.
go back to reference Catalano PM, Tyzbir ED, Wolfe RR et al (1993) Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264:E60–E67PubMed Catalano PM, Tyzbir ED, Wolfe RR et al (1993) Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264:E60–E67PubMed
5.
go back to reference Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 48:848–854PubMedCrossRef Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 48:848–854PubMedCrossRef
6.
go back to reference Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568–573PubMedCrossRef Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568–573PubMedCrossRef
7.
go back to reference Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491PubMed Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491PubMed
8.
go back to reference Watanabe RM, Allayee H, Xiang AH et al (2007) Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 56:1481–1485PubMedCrossRef Watanabe RM, Allayee H, Xiang AH et al (2007) Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 56:1481–1485PubMedCrossRef
9.
go back to reference Chen Z, Black MH, Watanabe RM et al (2013) Self-reported physical activity is associated with beta-cell function in Mexican American adults. Diabetes Care 36:638–644PubMedCrossRef Chen Z, Black MH, Watanabe RM et al (2013) Self-reported physical activity is associated with beta-cell function in Mexican American adults. Diabetes Care 36:638–644PubMedCrossRef
10.
go back to reference Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512–1527PubMedCrossRef Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512–1527PubMedCrossRef
11.
go back to reference Black MH, Fingerlin TE, Allayee H et al (2008) Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57:1048–1056PubMedCrossRef Black MH, Fingerlin TE, Allayee H et al (2008) Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57:1048–1056PubMedCrossRef
12.
go back to reference Li X, Allayee H, Xiang AH et al (2009) Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring) 17:729–736CrossRef Li X, Allayee H, Xiang AH et al (2009) Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring) 17:729–736CrossRef
13.
go back to reference Shu YH, Hartiala J, Xiang AH et al (2009) Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. J Clin Endocrinol Metab 94:4094–4102PubMedCrossRef Shu YH, Hartiala J, Xiang AH et al (2009) Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. J Clin Endocrinol Metab 94:4094–4102PubMedCrossRef
14.
go back to reference Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed
15.
go back to reference Kolonel LN, Henderson BE, Hankin JH et al (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151:346–357PubMedCrossRef Kolonel LN, Henderson BE, Hankin JH et al (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151:346–357PubMedCrossRef
16.
go back to reference Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN (2007) Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control 18:165–175PubMedCrossRef Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN (2007) Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control 18:165–175PubMedCrossRef
18.
go back to reference Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5:1003–1015PubMedCrossRef Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5:1003–1015PubMedCrossRef
19.
go back to reference Rosner B (2000) Fundamentals of biostatistics. Duxbury Press, Pacific Grove Rosner B (2000) Fundamentals of biostatistics. Duxbury Press, Pacific Grove
20.
go back to reference Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903–916PubMedCrossRef Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903–916PubMedCrossRef
21.
go back to reference Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2010) Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care 33:1798–1804PubMedCrossRef Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2010) Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care 33:1798–1804PubMedCrossRef
22.
go back to reference Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074–1079PubMedCrossRef Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074–1079PubMedCrossRef
23.
go back to reference Xiang AH, Kawakubo M, Trigo E, Kjos SL, Buchanan TA (2010) Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33:396–401PubMedCrossRef Xiang AH, Kawakubo M, Trigo E, Kjos SL, Buchanan TA (2010) Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33:396–401PubMedCrossRef
24.
go back to reference Kwak SH, Kim SH, Cho YM et al (2012) A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61:531–541PubMedCrossRef Kwak SH, Kim SH, Cho YM et al (2012) A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61:531–541PubMedCrossRef
25.
go back to reference Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8:639–649PubMedCrossRef Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8:639–649PubMedCrossRef
26.
go back to reference Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803PubMedCrossRef Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803PubMedCrossRef
27.
go back to reference Xiang AH, Peters RK, Kjos SL et al (2006) Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55:517–522PubMedCrossRef Xiang AH, Peters RK, Kjos SL et al (2006) Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55:517–522PubMedCrossRef
28.
go back to reference Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779PubMedCrossRef Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779PubMedCrossRef
Metadata
Title
Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus
Authors
Anny H. Xiang
Miwa Takayanagi
Mary Helen Black
Enrique Trigo
Jean M. Lawrence
Richard M. Watanabe
Thomas A. Buchanan
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3048-0

Other articles of this Issue 12/2013

Diabetologia 12/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.